
Op-Ed: Which Injections Should Investors Watch in 2021?
Everyone is eager for vaccine news and numbers, but longtime investor Tony Waskiewicz argues the real portfolio boosters will be any actions from the Fed and Congress.
Forget the 12 days of Christmas: Today marks the beginning of the traditional year-end market jump, LPL says, if it happens.
An LPL historical study shows the tricky dynamics for stocks in the year’s final two months.
Not really, says UBS’s Haefele, sounding optimistic on vaccines and possible fresh aid in 2021.
So say two savants from Principal Financial, at CIO’s Summit.